SCHEMBL7299644

SCHEMBL7299644

CC(C)[C@H](NC(=O)c1ccc2ccccc2n1)C(=O)N[C@@H](Cc1ccccc1)[C@@H]1O[C@@H]1[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)c1ccc2ccccc2n1)C(C)C

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSD P07339 2/20 0.62
CCR1 P32246 1/20 0.50
OPRM1 P35372 1/20 0.44
OPRK1 P41145 1/20 0.44
TMEM97 Q5BJF2 1/20 0.44
SIGMAR1 Q99720 1/20 0.44
CTSK P43235 3/20 0.43
CTSL P07711 1/20 0.43
CTSB P07858 1/20 0.43
CTSS P25774 1/20 0.43
GAA P10253 2/20 0.43
ALDH1A1 P00352 2/20 0.43
MAPT P10636 1/20 0.43
KDM4C Q9H3R0 1/20 0.42
HDAC1 Q13547 1/20 0.42
NFKB1 P19838 1/20 0.41
RAB9A P51151 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8801074 0.90 CTSD (0.69) CTSDCCR1OPRM1OPRK1TMEM97
SCHEMBL8801114 0.87 CTSD (0.66) CTSDCCR1OPRM1OPRK1TMEM97
SCHEMBL6446189 0.83 CCR1 (0.53) CTSDCCR1OPRM1OPRK1TMEM97
SCHEMBL8800567 0.83 CTSD (0.61) CTSDCCR1ALDH1A1MAPTHDAC1
SCHEMBL6446710 0.82 CCR1 (0.60) CTSDCCR1OPRM1OPRK1TMEM97
SCHEMBL6447672 0.82 CCR1 (0.60) CTSDCCR1OPRM1OPRK1TMEM97
SCHEMBL6448536 0.82 CCR1 (0.60) CTSDCCR1OPRM1OPRK1TMEM97
SCHEMBL7298042 0.82 CTSD (0.60) CTSDCCR1CTSKCTSLCTSB
SCHEMBL7299914 0.82 CASP3 (0.49) CTSD
SCHEMBL8800743 0.82 CTSD (0.59) CTSDCCR1ALDH1A1MAPTHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0575097-B1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS LILLY CO ELI (US) 2000-11-02 EP disclosed
US-5578608-A HIV PROTEASE INHIBITOR ELI LILLY AND COMPANY (US) 1996-11-26 US disclosed
EP-0575097-A1 2,3-Bis-carboxamidomethyl substituted oxiranes as inhibitors of HIV protease and their use for the treatment of AIDS ELI LILLY AND COMPANY (US) 1993-12-22 EP disclosed